MDER (Medera) Ending Cash Position: $1.21 Mil (As of Jun. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Medera Ending Cash Position?

Medera MDER Ending Cash Position is $1.21 Mil as of Jun. 2024.

Medera's Ending Cash Position for the quarter that ended in Jun. 2024 was $1.21 Mil.

Medera's quarterly Ending Cash Position increased from Jun. 2023 ($0.35 Mil) to Dec. 2023 ($0.42 Mil) and increased from Dec. 2023 ($0.42 Mil) to Jun. 2024 ($1.21 Mil).

Medera's annual Ending Cash Position increased from . 20 ($0.00 Mil) to Dec. 2022 ($1.51 Mil) but then declined from Dec. 2022 ($1.51 Mil) to Dec. 2023 ($0.42 Mil).

Medera Ending Cash Position Related Terms

Medera Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Medera's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medera Ending Cash Position Chart

Medera Annual Data
Trend Dec22 Dec23
Ending Cash Position
1.51 0.42

Medera Semi-Annual Data
Dec22 Jun23 Dec23 Jun24
Ending Cash Position 0.00 0.35 0.42 1.21

Medera Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Medera's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=1.511+-1.096
=0.42

Medera's Ending Cash Position for the quarter that ended in Jun. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0.417+0.791
=1.21

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $1.21 Mil mean?
Medera (MDER) has a Ending Cash Position of $1.21 Mil as of Jun. 2024. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Medera and its competitors.
Is Medera's Ending Cash Position too high?
Medera's current Ending Cash Position is $1.21 Mil.
How does Medera's Ending Cash Position compare to ?
Medera's Ending Cash Position of $1.21 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Biotechnology company?
A good Ending Cash Position depends on the Biotechnology industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Medera and its competitors. Medera's current Ending Cash Position is $1.21 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medera stock overvalued right now?
Medera (MDER) has a current Ending Cash Position of $1.21 Mil. The current Ending Cash Position is $1.21 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Medera (MDER), the current Ending Cash Position is $1.21 Mil as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medera Business Description

Comparable Companies
Address 6 Tide Street, 2nd Floor, Boston, MA, USA, 02210
Medera Inc is a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases by developing a range of next-generation therapeutics. Medera operates through two arms, namely: (1) pre-clinical disease modeling and drug discovery under Medera's Novoheart brand, which includes its bioengineered human mini-heart technology platform and related state-of-the-art technologies for preclinical screening; and (2) clinical development of novel therapies under Medera's Sardocor brand, which aspires to create the shortest regulatory path to clinic for advancing next-generation gene therapies (by leveraging the above Novoheart platform), in particular, for cardiovascular diseases.